Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

Aerang Kim, Brigitte C. Widemann, Mark Krailo, Nalini Jayaprakash, Elizabeth Fox, Brenda Weigel, Susan M. Blaney

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint Dive into the research topics of 'Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences